Diseases, Conditions, Syndromes

Drug-resistant tuberculosis: A new study offers new hope

Tuberculosis (TB) is the leading cause of death in the world from a single infectious disease, causing more deaths than HIV/AIDS. In 2017, 10 million people developed TB disease globally and an estimated 1.6 million died.

Diseases, Conditions, Syndromes

Aspirin to fight an expensive global killer infection

Research led by the Centenary Institute in Sydney has found a brand new target for treating drug-resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood ...

Diseases, Conditions, Syndromes

Deadly drug-resistant TB a 'blinking red' global threat

Deadly, drug-resistant tuberculosis—as lethal as Ebola and tough to treat in even the best hospitals—is a "blinking red" worldwide threat, the head of a global health fund warned in an interview with AFP.

Diseases, Conditions, Syndromes

How drug resistant TB evolved and spread globally

The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

Diseases, Conditions, Syndromes

Governments to discuss tackling tuberculosis at UN summit

Governments from around the world will gather Wednesday to discuss the persistent scourge of tuberculosis, which last year claimed more lives than any other communicable disease.

page 1 from 10

Tuberculosis treatment

Active tuberculosis will kill about two of every three people affected if left untreated. Treated tuberculosis has a mortality rate of less than 5%.

The standard "short" course treatment for tuberculosis (TB), is isoniazid, rifampicin, pyrazinamide, and ethambutol for two months, then isoniazid and rifampicin alone for a further four months. The patient is considered cured at six months (although there is still a relapse rate of 2 to 3%). For latent tuberculosis, the standard treatment is six to nine months of isoniazid alone.

If the organism is known to be fully sensitive, then treatment is with isoniazid, rifampicin, and pyrazinamide for two months, followed by isoniazid and rifampicin for four months. Ethambutol need not be used.

This text uses material from Wikipedia, licensed under CC BY-SA